MODERN APPROACHES IN TREATMENT OF PATIENTS OF MULTIPLE MYELOMES (references review)
https://doi.org/10.51523/2708-6011.2009-6-4-1
Abstract
Multiple myelomes (MM) is the B-cellular tumor which is characterized by accumulation of plasmatic cells in bone morrow.
About the Author
I. A. Iskrov
Republican Scientifically-practical Centre of Radiating Medicine and Human Ecology
Belarus
Belarus
References
1. Бессмельцев, С. С. Современные подходы к химиотерапии множественной миеломы / С. С. Бессмельцев // Медико-фармацевтический форум (29 окт. - 2 нояб.): тез. докл. - М., 2002. - С. 36-37.
2. Blokhin, N. [et al.] // Ann NY Acad Sci. - 1958. - Vol. 68. - P. 1128-1132
3. Cancer Chemother.Rep. - 1962. - Vol. 21. - P. 87-99.
4. Bergsagel, D. E. Some unusual manifestations of plasma cell neoplasma / D. E. Bergsagel, P. W. Pruzanski // Neoplastic disease of the Blood / Ed. P. H. Wiernik. - N.-Y., 1985. - P. 553-573.
5. A methodological evaluation of 15 controlled clinical trials in myelomatosis / H. S. Birgens [et al.] // Scand. J. Haematol. - 1985. - Vol. 35. - P. 26-34.
6. Peptichemio, vincristine, prednisone induction treatment in multiple myeloma / G. Merlini [et al.] // Tummori. - 1985. - Vol. 71. - P. 581-588.
7. Treatment of multiple myeloma in old patients / I. P. Palva [et al.] // Eur. J. Haematol. - 1989. - Vol. 43. - P. 328-331.
8. Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cytostatic policy. Cooperative Group of Study and Treatment of Multiple myeloma / A. Riccardi [et al.] // Br. J. Cancer. - 1994. - Vol. 70. - P. 1203-1210.
9. Westin, J. Conventional chemotherapy in multiple myeloma / J. Westin // Pathol. Biol. (Paris). - 1999. - Vol. 47. - P. 169-171.
10. The therapeutic efficacy of VBCMP-M2 protocol in multiple myeloma / M. D. Colovic [et al.] // Haematologica (Budap). - 1994. - Vol. 26. - P. 91-96.
11. Complete remission induction with combined VBMCP chemotherapy and interferon in patients with multiple myeloma / M. M. Oken [et al.] // Leuk. Lymphoma. - 1996. - Vol. 20. - P. 447-452.
12. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479 / M. M. Oken [et al.] // Cancer. - 1997. - Vol. 79. - P. 1561-1567.
13. McElwain, T. J. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma / T. J. McElwain, R. L. Powles. - Lancet. - 1983. - Vol. 2. - P. 822-824.
14. Multiple myeloma treated with high dose intravenous melphalan / P. J. Selby [et al.] // Br J Haematol. - 1987. - Vol. 66. - P. 55-62
15. Barlogie, B. [et al.] // Blood. - 1987. - Vol. 70. - P. 869-872.
16. Attal, M. [et al.] // N. Engl J Med. - 1996. - Vol. 335. - P. 91-97.
17. Child, J. A. [et al.] // Ibid. - 2003. - Vol. 348. - P. 1875-1883.
18. Blade, J. [et al.] // Ibid. - 2001. - Vol. 98. - P. 815a.
19. Intergroupe Francais du Myelome. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma / M. Attal [et al.] // N Engl J Med. - 1996. - Vol. 335. - P. 91-97.
Review
For citations:
Iskrov I.A. MODERN APPROACHES IN TREATMENT OF PATIENTS OF MULTIPLE MYELOMES (references review). Health and Ecology Issues. 2009;(4):7-12. (In Russ.) https://doi.org/10.51523/2708-6011.2009-6-4-1
Views: 261
Email this article 